Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Paxil – SSRI for the Treatment of Major Depressive Disorders, United States of America



Paxil (paroxetine hydrochloride) is an orally administered psychotropic drug for the treatment of major depressive disorders.


Back to Project Details



Related Projects

Erbitux (Cetuximab)
Erbitux is a chimaeric monoclonal antibody (MAb) that is specific for...

Acomplia (Rimonabant) - Investigational Agent for the Management of Obesity
Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective...

Xolair - Biological Therapy
The product of a joint development programme between Tanox, Genentech...

Exanta - Oral Direct Thrombin Inhibitor for the
Exanta (ximelagatran) is an oral Direct Thrombin Inhibitor (DTI)...

Prexige - COX-2 Inhibitor
Prexige (lumiracoxib) is an innovative COX-2 inhibitor developed by...

See all projects


Twitter Twitter    Facebook Facebook   
Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2012 Net Resources International, a trading division of SPG Media Limited.